We're working on something new at CrunchBase. Edits have been disabled for a few days, but you can still contact us for urgent changes.
Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitetpgbiotech.com
Phone415.743.1500
Employees
Descriptionprivate equity

Funds

Offices

HQ
345 California Street
Suite 3300
San Francisco, CA, 94104
USA

People

Partner, Managing Director
Partner and Managing Director
Partner and Managing Director
Managing Director
Managing Director
Vice President
Principal
Principal
Show All People

Tags

TPG Biotech

TPG Biotech is part of the growth equity and venture investment platform of TPG, the global private investment firm. TPG Biotech targets investments in pharmaceutical discovery and development, medical technology, diagnostics, healthcare and pharmaceutical services, life sciences, as well as industrial applications of biotechnology. TPG Biotech has access to the broader resources of TPG.

Recent Milestones

Investments

Company Date Round Size Participants
Epirus Biopharmaceuticals 4/2014Series B$36M7
Rapid Micro Biosystems 4/2014Venture Round$6M5
DNAnexus 1/2014Series C$15M4
PatientSafe Solutions 9/2013Series C$7M4
Auxogyn 9/2013Series B$5.53M4
Otonomy 9/2013Series C$45.9M8
Veracyte 6/2013Series C$28M5
Rapid Micro Biosystems 6/2013Series B$32.6M5
Alphabet Energy 3/2013Series B$16M4
Auxogyn 6/2012Series B$18M4
Alder Biopharmaceuticals 4/2012Series D$38M7
Auxogyn 2/2012Series A$20M3
Roka Bioscience 1/2012Series D$47.5M4
Elevation Pharmaceuticals 1/2012Series B$30M5
DNAnexus 10/2011Series B$15M6
Alphabet Energy 9/2011Series A$12M3
Roka Bioscience 7/2011Series C$20M4
CardioDx 5/2011Private Equity$60M14
Aerie Pharmaceuticals 3/2011Series B$41.4M5
Elevance Renewable Sciences 12/2010Series C$100M4

Videos

Sources

  1. Epirus Biopharmaceuticals Closes $36M Series B Financing (finsmes.com) [edit]
  2. SEC (sec.gov) [edit]
  3. DNAnexus Closes $15M Series C Funding (finsmes.com) [edit]
  4. PatientSafe Solutions Receives $7M Investment from EDBI; Close $27m series c (finsmes.com) [edit]
  5. SEC (sec.gov) [edit]
  6. Otonomy completes $45.9m Series C financing (finsmes.com) [edit]
  7. Veracyte Completes $28 Million Series C Financing (finsmes.com) [edit]
  8. Rapid Micro Biosystems Raises $32.6M In Series B Financing (finsmes.com) [edit]
  9. Alphabet Energy Raises $16M in Series B Financing (finsmes.com) [edit]
  10. Auxogyn Raises $18M in Series B Financing (finsmes.com) [edit]
  11. Alder BioPharmaceuticals Inc. Closes $38 Million Series D Financing to Accelerate Clinical Development of its Pipeline of Antibody Therapeutics (prnewswire.com) [edit]
  12. Auxogyn raises $20M in Series A funds (bizjournals.com) [edit]
  13. Roka Bioscience Secures $47.5 Million in Series D Financing (prnewswire.com) [edit]
  14. Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy (elevationpharma.com) [edit]
  15. DNAnexus Raises $15 Million, Teams With Google To Host Massive DNA Database (techcrunch.com) [edit]
  16. Alphabet Energy Raises $12M in Series A Financing (finsmes.com) [edit]
  17. Roka Bioscience Completes $20M Series C Equity Financing (finsmes.com) [edit]
  18. CardioDx Closes $60m Financing Round (finsmes.com) [edit]
  19. SEC (sec.gov) [edit]
  20. Elevance Renewable Sciences Raises $100 Million in Series C Financing (prnewswire.com) [edit]
Edit This Page
Last Edited 4/16/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

TechCrunch Posts TechCrunch Logo Small Picture

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy